Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?

Amyloid. 2017 Mar;24(sup1):132-133. doi: 10.1080/13506129.2016.1272453.

Authors

Fabian Aus dem Siepen¹, Selina Hein¹, Ralf Bauer¹, Hugo A Katus¹, Arnt V Kristen¹

Affiliation

¹ a Department of Cardiology , University Hospital Heidelberg , Heidelberg , Germany.

PMID: 28434295
DOI: 10.1080/13506129.2016.1272453

No abstract available

MeSH terms

Aged
Amyloid Neuropathies, Familial / drug therapy*
Amyloid Neuropathies, Familial / metabolism
Amyloid Neuropathies, Familial / mortality
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Female
Heart Failure / drug therapy*
Heart Failure / metabolism
Heart Failure / mortality
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Retrospective Studies

Substances

Angiotensin-Converting Enzyme Inhibitors

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related